Cargando…
Do gabapentin or pregabalin directly modulate the µ receptor?
BACKGROUND: Pregabalin and gabapentin improve neuropathic pain symptoms but there are emerging concerns regarding their misuse. This is more pronounced among patients with substance use disorder, particularly involving opioids. Co-ingestion of gabapentinoids with opioids is increasingly identified i...
Autores principales: | Manandhar, Preeti, Murnion, Bridin Patricia, Grimsey, Natasha L., Connor, Mark, Santiago, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048397/ https://www.ncbi.nlm.nih.gov/pubmed/33954038 http://dx.doi.org/10.7717/peerj.11175 |
Ejemplares similares
-
Tapentadol shows lower intrinsic efficacy at µ receptor than morphine and oxycodone
por: Manandhar, Preeti, et al.
Publicado: (2022) -
Gabapentinoids: Gabapentin and Pregabalin for Postoperative Pain Management
por: Imani, Farnad, et al.
Publicado: (2012) -
Mirogabalin: could it be the next generation gabapentin or pregabalin?
por: Kim, Jae-Yeon, et al.
Publicado: (2021) -
Rational dosing of gabapentin and pregabalin in chronic kidney disease
por: Raouf, Mena, et al.
Publicado: (2017) -
Potential Adverse Consequences of Combination Therapy with Gabapentin and Pregabalin
por: Ghayur, Muhammad Nabeel
Publicado: (2021)